Iron Bisglycinate – Delayed-Release Matrix Powder
Iron Bisglycinate – Delayed-Release Matrix Powder
Couldn't load pickup availability
Ferrous bisglycinate is iron chelated with two glycine molecules, typically supplying about 20% elemental iron. It is valued for its gentle gastrointestinal profile, good absorption and neutral taste compared with classic iron salts, making it a preferred form in premium supplements.
Delayed-release matrix powder engineered to protect the active through the stomach and support release further along the gut.
GUTINS Iron Bisglycinate — delayed-release matrix powder is offered for manufacturers, formulators and brands. Specification: active assay + encapsulation efficiency; form / technology: delayed-release matrix powder; diet suitability: Verify carrier.
Product Specifications
| Product | Iron Bisglycinate — delayed-release matrix powder |
|---|---|
| Category | Microencapsulated & Delivery-System Ingredients |
| Subcategory | Microencapsulation / controlled release |
| Base Ingredient / Source | Iron Bisglycinate |
| Scientific Name | Iron(II) bis(glycinate) |
| Specification / Assay | active assay + encapsulation efficiency |
| Form / Technology | delayed-release matrix powder |
| Source Type | Ingredient-specific |
| Diet Suitability | Verify carrier |
| CAS Number | 20150-34-9 |
| Solubility | Matrix limits dissolution in acidic media; disperses at intestinal pH. Parent active: soluble to sparingly soluble in water; insoluble in oils and ethanol |
| Trend / Positioning | Delivery system |
| Available Pack Sizes | 50 g, 225 g, 1 Kg, 5 Kg (larger volumes on request) |
| Documentation | CoA, TDS and SDS available on request |
Key Benefits
- Supports normal red blood cell formation and oxygen transport
- Contributes to reduced tiredness and fatigue
- Gentle on the stomach compared with ferrous sulfate
- Good absorption, less affected by dietary inhibitors
- Low metallic taste for chewables and drinks
Uses & Applications
Typical applications: Premixes, gummies, sachets, tablets, beverages.
- Gentle iron capsules and tablets
- Prenatal multivitamins
- Iron gummies and chewables
- Fortified drink mixes and sachets
- Sports and endurance recovery formulas
- Multimineral premixes
How to Use / Dosage
- Typical daily intake: 14–30 mg/day elemental iron (approx. 70–150 mg chelate at ~20% Fe)
- Typical use level: 0.1–1% in multimineral powders; 5–30% in iron capsule fills; 0.005–0.05% in fortified beverages
- Formulation tip: Avoid milling or high-shear processing that could compromise the release matrix.
- Weigh accurately and pre-blend small quantities with a carrier (e.g. maltodextrin, MCC or rice flour) for uniform distribution.
- Final dosage should be based on the lot-specific Certificate of Analysis, the target serving size and the rules of your destination market.
Solubility & Formulation
Matrix limits dissolution in acidic media; disperses at intestinal pH. Parent active: soluble to sparingly soluble in water; insoluble in oils and ethanol
Storage & Handling
Store tightly closed in a cool, dry place (below 25 °C) protected from moisture and light.. Keep container tightly closed; use clean, dry utensils. Shelf life is typically 24 months in unopened original packaging (see CoA).
Regulatory Note
Ferrous bisglycinate is GRAS (self-affirmed/notified) in the US and listed as a permitted iron source in EU supplements (Directive 2002/46/EC) and foods; FDA iron overdose warning applies. Verify maximum levels and FSSAI/Health Canada monographs in the destination market.
Diet suitability: Verify carrier. This product is supplied as a raw ingredient for further manufacturing and is not a finished consumer product. The buyer is responsible for ensuring the ingredient, its use level and all label claims comply with the regulations of the destination market (e.g. FDA, EFSA, FSSAI, Health Canada, TGA).
Caution & Disclaimer
- Iron can be harmful in excess: keep out of reach of children (accidental iron overdose is dangerous); US UL 45 mg/day elemental iron
- Reduces absorption of levothyroxine, tetracyclines, quinolones and levodopa – separate dosing by 2–4 h
- Not for people with haemochromatosis or iron overload unless medically advised
- Pregnant women should use iron at doses advised by a healthcare professional
For manufacturing, formulation and professional use only. Not for direct consumption in concentrated form. Keep out of reach of children. Avoid inhalation of dust and contact with eyes; use suitable PPE when handling. Consult a qualified healthcare professional before use if pregnant, nursing, taking medication or managing a medical condition. These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.
Bulk & Wholesale Orders
Need more than 5 Kg, a custom specification, private label support or documentation (CoA, TDS, SDS, allergen and GMO statements)? Contact the GUTINS team for bulk pricing and lead times.